In late 2011, a year after swine flu outbreaks in India, three vaccine manufacturers were contracted for nearly two million doses of H1N1 vaccine to the government. Serum Institute of India, Bharat Biotech and Panacea Biotec had obtained licenses for their products the previous year, invested in new plants and were all set to supply the doses. For the paediatric vaccine makers, this was the first big step towards adult vaccines and a whole new market. Today, those expired doses are dumped in warehouses. The plants lay idle as the companies await closure of an…
Weapons of Mass Protection
Lost in India—Flu vaccines
From orders for two million H1N1 flu vaccines from the government in 2011 to the disappearance from a booming flu vaccine market in 2017. The real story of Indian vaccine makers
Sign up to read this story for free right now
Stories on The Ken are available only for its subscribers. Join us now to get instant access.
Complete access to all stories on The Ken.
Rs. 2,750/year or Rs. 1,200/quarter
All free stories published, past and upcoming
Have an account? Login now